Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07005050 · ClinicalTrials.gov registry record · NA
Renal Pelvic Denervation Pilot Trial
A NA study of Uncontrolled Hypertension, sponsored by Verve Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 5
- Study locations
NCT07005050 is a NA study of Uncontrolled Hypertension that is actively recruiting participants, run by Verve Medical. The registered enrollment target is 60 participants, below the 758-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT07005050, a NA study of Uncontrolled Hypertension, is actively recruiting participants, sponsored by Verve Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 5
- Study locations
Study Summary
The RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled blood pressure despite use of two medications at a therapeutic dose. The novelty of the RPDTM system relates to its placement via natural orifice into the renal pelvis (bilaterally) for delivery of radiofrequency energy to ablate the nerves that pass through the outer wall of the renal pelvis, a technique referred to as renal pelvic denervation (RPD).
Conditions Studied
Interventions
- DEVICE RPD
- DRUG Active hypertension medical therapy
Study Locations (5)
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic - Rochester
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Panoramic Health / Southwest Kidney Institute, PLC - Surprise
Nevada
- DaVita Clinical Research - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-12-30 |
| Est. Completion | 2029-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07005050
The ClinicalTrials.gov registry entry for NCT07005050 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 758-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (92% lower). The listed sponsor is Verve Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uncontrolled Hypertension appearing as the primary indexed condition, and to 2 interventions - of which RPD is the first listed.
NCT07005050 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT07005050 about?
NCT07005050 is a clinical study titled "Renal Pelvic Denervation Pilot Trial". The RPD Pilot trial will evaluate the safety and effectiveness of Verve Medical's RPDTM renal denervation system for hypertensive patients with uncontrolled blood pressure despite use of two medications at a therapeutic dose. The novelty of the RPDTM system relates to its placement via natural orif...
What is the current status of trial NCT07005050?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-12-30. Estimated completion is 2029-03-02.
What conditions does trial NCT07005050 study?
This clinical trial studies the following conditions: Uncontrolled Hypertension.
What interventions are being tested in trial NCT07005050?
The interventions under investigation include: RPD (DEVICE), Active hypertension medical therapy (DRUG).
Who is sponsoring clinical trial NCT07005050?
This trial is sponsored by Verve Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07005050 being conducted?
This trial has 5 study locations across Alabama, Arizona, Minnesota, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uncontrolled Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
RECRUITING · NA
-
Wearable Evaluation of Ambulatory Readings for Blood Pressure
RECRUITING · NA
-
Remote Hypertension Management for Black Patients
RECRUITING · NA
-
Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.
ACTIVE NOT RECRUITING · NA
-
Technology Coaching Intervention for Black Women With Hypertension
COMPLETED · NA
-
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.